Search

We present a genome assembly from an individual male Adalia decempunctata (the ten-spot ladybird; Arthropoda; Insecta; Coleoptera; Coccinellidae). The genome sequence is 489.4 megabases in span. Most of the assembly is scaffolded into 12 chromosomal pseudomolecules, including the X and Y sex chromosomes. The mitochondrial genome has also been assembled and is 19.68 kilobases in length.

The Global Ocean Data Analysis Project (GLODAP) is a synthesis effort providing regular compilations of surface to bottom ocean biogeochemical bottle data, with an emphasis on seawater inorganic carbon chemistry and related variables determined through chemical analysis of seawater samples. GLODAPv2.2023 is an update of the previous version, GLODAPv2.2022 (Lauvset et al., 2022). The major changes are as follows: data from 23 new cruises were added. In addition, a number of changes were made to the data included in GLODAPv2.2022. GLODAPv2.2023 includes measurements from more than 1.4 million water samples from the global oceans collected on 1108 cruises. The data for the now 13 GLODAP core variables (salinity, oxygen, nitrate, silicate, phosphate, dissolved inorganic carbon, total alkalinity, pH, chlorofluorocarbon-11 (CFC-11), CFC-12, CFC-113, CCl4, and SF6) have undergone extensive quality control with a focus on the systematic evaluation of bias. The data are available in two formats: (i) as submitted by the data originator but converted to World Ocean Circulation Experiment (WOCE) exchange format and (ii) as a merged data product with adjustments applied to minimize bias. For the present annual update, adjustments for the 23 new cruises were derived by comparing those data with the data from the 1085 quality-controlled cruises in the GLODAPv2.2022 data product using crossover analysis. SF6 data from all cruises were evaluated by comparison with CFC-12 data measured on the same cruises. For nutrients and ocean carbon dioxide (CO2), chemistry comparisons to estimates based on empirical algorithms provided additional context for adjustment decisions. The adjustments that we applied are intended to remove potential biases from errors related to measurement, calibration, and data-handling practices without removing known or likely time trends or variations in the variables evaluated. The compiled and adjusted data product is believed to be consistent to better than 0.

The ocean biological carbon pump (BCP) plays a pivotal role in the global carbon cycle. The BCP magnitude is determined by the fraction of nutrients utilised in biological production and remineralised at depth, with the remainder being subducted into the interior unused as ‘preformed’ nutrients. This fraction is currently around 50% and subject to the interaction of biological processes and global scale circulation. Consequently, changes in circulation can potentially impact biological carbon storage. Here we provide observational evidence that the reduction in the Atlantic Meridional Overturning Circulation (AMOC) that occurred over the 2004-2018 period has been accompanied by substantial changes in nutrient transports and associated carbon storage. Persistent southward net nutrient transport across 26.5°N exceeded nutrient sources, except by the end of the period when the system approached balance. This transient net loss of nutrients from the North Atlantic was accompanied by increases in the ratio of remineralized to preformed nutrients, indicating an increasing BCP efficiency (and carbon storage). Our results thus demonstrate observable transient changes in large scale nutrient transports linked to AMOC changes over interannual - decadal timescales, with implications for future ocean carbon storage.

Physical properties of ten millimeter-sized meteoroids from the Southern Delta Aquariids (SDA) shower are derived using optical observations from the Canadian Automated Meteor Observatory between 2020 and 2023. The meteors are found to ablate in two distinct erosion stages, the second stage showing a single, bright leading fragment. Our modelling interprets these observations as evidence for equal masses of compact grains embedded in a porous, low density matrix. The average bulk density of SDA meteors is found to be 1,420 $\pm$ 100 $\rm{kg \ m^{-3}}$, with the compact component having a density of 2,310 $\pm$ 160 $\rm{kg \ m^{-3}}$ and the porous component a density of $700\pm110$ $\rm{kg \ m^{-3}}$. The high bulk density of SDA meteors is comparable to densities found for the Quadrantid and Geminid showers, both of which also have low perihelion distances. This suggests that thermal desorption may play a significant role in the processing of meteoroids., Comment: Accepted for publication in Monthly Notices of the Royal Astronomical Society, 17 pages, 13 figures

We present a method of extrapolating the spectroscopic behavior of Type Ia supernovae (SNe Ia) in the near-infrared (NIR) wavelength regime up to 2.30 $\mu$m using optical spectroscopy. Such a process is useful for accurately estimating K-corrections and other photometric quantities of SNe Ia in the NIR. Principal component analysis is performed on data consisting of Carnegie Supernova Project I & II optical and near-infrared FIRE spectra to produce models capable of making these extrapolations. This method differs from previous spectral template methods by not parameterizing models strictly by photometric light-curve properties of SNe Ia, allowing for more flexibility of the resulting extrapolated NIR flux. A difference of around -3.1% to -2.7% in the total integrated NIR flux between these extrapolations and the observations is seen here for most test cases including Branch core-normal and shallow-silicon subtypes. However, larger deviations from the observation are found for other tests, likely due to the limited high-velocity and broad-line SNe Ia in the training sample. Maximum-light principal components are shown to allow for spectroscopic predictions of the color-stretch light-curve parameter, $s_{BV}$, within approximately $\pm$0.1 units of the value measured with photometry. We also show these results compare well with NIR templates, although in most cases the templates are marginally more fitting to observations, illustrating a need for more concurrent optical+NIR spectroscopic observations to truly understand the diversity of SNe Ia in the NIR., Comment: 25 pages, 16 figures, ApJ, in press

We present comprehensive optical observations of SN~2021gmj, a type II supernova (SN~II) discovered within a day of explosion by the Distance Less Than 40~Mpc (DLT40) survey. Follow up observations show that SN~2021gmj is a low luminosity SN~II (LL~SN~II), with a peak magnitude $M_V = -15.45$ and Fe II velocity of $\sim 1800 \ \mathrm{km} \ \mathrm{s}^{-1}$ at 50 days past explosion. Using the expanding photosphere method we derive a distance of $17.8^{+0.6}_{-0.4}$~Mpc. From the tail of the light-curve we obtain a radioactive nickel mass of $0.014 \pm 0.001$ $\mathrm{M}_{\odot}$. The presence of circumstellar material (CSM) is suggested by the early light curve, early spectra and the presence of high velocity H$\alpha$ in absorption. Analytical shock-cooling models of the early light curve cannot reproduce the fast rise, also supporting the idea that the early emission is partially powered by the interaction of the SN ejecta and CSM. The inferred low CSM mass of 0.025 $\mathrm{M}_{\odot}$ in our hydrodynamic-modeling light curve analysis is also consistent with our spectroscopic observations. We observe a broad feature near 4600 A, which may be high ionization lines of C, N or/and He II. This feature is reproduced by radiation hydrodynamic simulations of red supergiants with extended atmospheres. Several LL~SNe~II show similar spectral features implying that high density material around the progenitor may be common among them., Comment: Submitted to ApJ

Outcome data of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) beyond the second line are scarce outside of clinical trials. Novel therapies in the R/R setting have been approved based on single-arm trials, but results need to be contextualized by real-world outcomes. Medical records from 3753 Danish adults diagnosed with DLBCL were reviewed. Patients previously treated with rituximab and anthracycline-based chemotherapy who received the third or later line (3 L+) of treatment after 1 January 2015, were included. Only 189 patients with a median age of 71 years were eligible. The median time since the last line of therapy was 6 months. Patients were treated with either best supportive care (22%), platinum-based salvage therapy (13%), low-intensity chemotherapy (22%), in clinical trial (14%) or various combination treatments (32%). The 2-year OS-/PFS estimates were 25% and 12% for all patients and 49% and 17% for those treated with platinum-based salvage therapy. Age ≥70, CNS involvement, elevated LDH and ECOG ≥2 predicted poor outcomes, and patients with 0–1 of these risk factors had a 2-year OS estimate of 65%. Only a very small fraction of DLBCL patients received third-line treatment and were eligible for inclusion. Outcomes were generally poor, but better in intensively treated, fit young patients with limited disease., Outcome data of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) beyond the second line are scarce outside of clinical trials. Novel therapies in the R/R setting have been approved based on single-arm trials, but results need to be contextualized by real-world outcomes. Medical records from 3753 Danish adults diagnosed with DLBCL were reviewed. Patients previously treated with rituximab and anthracycline-based chemotherapy who received the third or later line (3 L+) of treatment after 1 January 2015, were included. Only 189 patients with a median age of 71 years were eligible. The median time since the last line of therapy was 6 months. Patients were treated with either best supportive care (22%), platinum-based salvage therapy (13%), low-intensity chemotherapy (22%), in clinical trial (14%) or various combination treatments (32%). The 2-year OS-/PFS estimates were 25% and 12% for all patients and 49% and 17% for those treated with platinum-based salvage therapy. Age ≥70, CNS involvement, elevated LDH and ECOG ≥2 predicted poor outcomes, and patients with 0–1 of these risk factors had a 2-year OS estimate of 65%. Only a very small fraction of DLBCL patients received third-line treatment and were eligible for inclusion. Outcomes were generally poor, but better in intensively treated, fit young patients with limited disease.

Why was the cohort set up? The number of cancer survivors is increasing worldwide, largely due to ageing populations, advances in early detection and cancer treatment.1 The 5-year prevalences of cancer survivors in Denmark have increased by almost 200% from 2000 to 2020, and close to 6% of the Danish population have been diagnosed with cancer.2 Extensive research has established that globally, but also in countries with equal and free access to health care, there is social inequality in stage at cancer diagnosis, treatment provided and survival.3 Since the introduction of cancer treatment by surgery, then radiation and later systemic chemotherapy, late effects have been a part of the aftermath accompanying survival. Late effects are defined as physiological and psychological symptoms or disorders which occur during or after end of treatment and which may become long-term or chronic.1 Little is known about social inequality in late effects. A Danish national study of 458 646 adult cancer survivors showed a significantly increased risk of other diseases in all but one of 11 major diagnostic groups, such as diseases in the nervous system and endocrine, cardiovascular, metabolic and respiratory disorders, for cancer survivors across cancer types up to 17 years after treatment compared with cancer-free individuals. This cohort study included only cancer survivors free of the diseases in the diagnostic group prior to the date of the cancer diagnosis.4 A prospective cohort from the USA of more than 12 000 people observed a 37% higher risk of cardiovascular disease and up to 52% higher risk of heart failure in adult cancer survivors compared with cancer-free individuals, depending on cancer type and treatment.5 Additionally, systematic reviews and meta-analyses found that up to 49% of cancer survivors suffer from fatigue6 and 47% suffer from pain.7 A Danish nationwide study reported that 57% have impaired sex life.8 Furthermore, a systematic review of 20 s

Cardiovascular diseases, especially congestive heart failure (CHF), are known complications of anthracyclines, but the risk for patients undergoing high-dose chemotherapy and autologous stem cell transplant (HDT-ASCT) is not well established. With T-cell therapies emerging as alternatives, studies of long-term complications after HDT-ASCT are warranted. Danish patients treated with HDT-ASCT for aggressive lymphoma between 2001 and 2017 were matched 1:5 on sex, birth year and Charlson comorbidity score to the general population. Events were captured using nationwide registers. A total of 787 patients treated with HDT-ASCT were identified. Median follow-up was 7.6 years. The risk of CHF was significantly increased in the HDT-ASCT population compared to matched comparators with an adjusted hazard ratio (HR) of 5.5 (3.8–8.1). The 10-year cumulative incidence of CHF was 8.0% versus 2.0% (p < 0.001). Male sex, ≥2 lines of therapy, hypertension and cumulative anthracycline dose (≥300 mg/m2) were risk factors for CHF. In a separate cohort of 4089 lymphoma patients, HDT-ASCT was also significantly associated with increased risk of CHF (adjusted HR of 2.6 [1.8–3.8]) when analysed as a time-dependent exposure. HDT-ASCT also increased the risk of other cardiac diseases. These findings are applicable for the benefit/risk assessment of HDT-ASCT versus novel therapies.

Introduction Treatment of lymphoma can be associated with cognitive challenges, and some patients may fear development of dementia as long-term complication. Studies report a lower risk of dementia after cancer. Some believe this difference to be a protective mechanism of cancer, others believe it to be driven by bias. The risk of developing dementia after lymphoma has not been investigated in a population-based setting. The aim of this study was to identify the risk of being diagnosed with dementia after lymphoma treatment. Materials and Methods This Danish nationwide matched cohort study included patients aged ≥65 years with a first-time diagnosis of a non-central nervous system lymphoma between 2005 and 2018 in complete remission after treatment with chemotherapy. Patients diagnosed with dementia or treated with dementia medication before lymphoma diagnosis were excluded. Each patient was matched 1:5 on sex, year of birth, and a modified Charlson comorbidity index. Patients and matched comparators were followed from the corresponding patient's date of complete remission. The risk of developing dementia was calculated using cause-specific hazard ratios (HR), and the cumulative risk was estimated by Aalen-Johansen with death as the competing risk. Results A total of 3,244 patients and 16,220 matched comparators were included in the study. There was no difference in risk of all-cause dementia among patients with lymphoma compared to matched comparators with cause-specific HR of 0.85 (95% confidence interval [CI]: 0.70;1.04). The risk of both Alzheimer's disease and non-Alzheimer's dementia was equal among patients and comparators: HR 0.89 (95% CI: 0.66;1.21) and 0.82 (95% CI: 0.63;1.07), respectively. Stratified by lymphoma subtype, age, or year of diagnosis, the risk of all-cause dementia remained equal among patients and matched comparators. The cumulative risk of all-cause dementia was significantly lower among patients with lymphoma, Introduction: Treatment of lymphoma can be associated with cognitive challenges, and some patients may fear development of dementia as long-term complication. Studies report a lower risk of dementia after cancer. Some believe this difference to be a protective mechanism of cancer, others believe it to be driven by bias. The risk of developing dementia after lymphoma has not been investigated in a population-based setting. The aim of this study was to identify the risk of being diagnosed with dementia after lymphoma treatment. Materials and Methods: This Danish nationwide matched cohort study included patients aged ≥65 years with a first-time diagnosis of a non-central nervous system lymphoma between 2005 and 2018 in complete remission after treatment with chemotherapy. Patients diagnosed with dementia or treated with dementia medication before lymphoma diagnosis were excluded. Each patient was matched 1:5 on sex, year of birth, and a modified Charlson comorbidity index. Patients and matched comparators were followed from the corresponding patient's date of complete remission. The risk of developing dementia was calculated using cause-specific hazard ratios (HR), and the cumulative risk was estimated by Aalen-Johansen with death as the competing risk. Results: A total of 3,244 patients and 16,220 matched comparators were included in the study. There was no difference in risk of all-cause dementia among patients with lymphoma compared to matched comparators with cause-specific HR of 0.85 (95% confidence interval [CI]: 0.70;1.04). The risk of both Alzheimer's disease and non-Alzheimer's dementia was equal among patients and comparators: HR 0.89 (95% CI: 0.66;1.21) and 0.82 (95% CI: 0.63;1.07), respectively. Stratified by lymphoma subtype, age, or year of diagnosis, the risk of all-cause dementia remained equal among patients and matched comparators. The cumulative risk of all-cause dementia was significantly lower among patients with lymphoma compared to matched com

In the current study, we report the prevalence of male testosterone deficiency in a cohort of 60 male long-term survivors of malignant lymphoma with normal total testosterone but in the lower part of the reference level. Testosterone deficiency was defined as subnormal concentrations of total testosterone or subnormal concentrations of calculated free testosterone. The aim was to clarify whether total testosterone was sufficient for identification of testosterone deficiency in male survivors of malignant lymphoma. Hormonal analyses taken at follow-up were compared with samples taken at diagnosis for a subgroup of 20 survivors, for evaluation of changes in hormones over time. Another group of 83 similar survivors of malignant lymphoma with testosterone in the high end of reference levels were also used for comparison, to identify groups of increased risk of testosterone deficiency. A total group of 143 survivors were therefore included in the study. Our findings indicate that for screening purposes an initial total testosterone is sufficient in some survivors because sexual hormone binding globulin concentration was found stable over time. However, 15% were found with subnormal calculated free testosterone. Survivors intensely treated for Hodgkin lymphoma and older survivors were identified as high-risk groups for testosterone deficiency necessitating endocrinological attention during follow-up. Some evidence of pituitary downregulation was also found, because of uncompensated decreases in testosterone concentration over time. In conclusion, longitudinal measurements of total testosterone alone do not seem adequate for the screening of testosterone deficiency for all long-term lymphoma survivors., In the current study, we report the prevalence of male testosterone deficiency in a cohort of 60 male long-term survivors of malignant lymphoma with normal total testosterone but in the lower part of the reference level. Testosterone deficiency was defined as subnormal concentrations of total testosterone or subnormal concentrations of calculated free testosterone. The aim was to clarify whether total testosterone was sufficient for identification of testosterone deficiency in male survivors of malignant lymphoma. Hormonal analyses taken at follow-up were compared with samples taken at diagnosis for a subgroup of 20 survivors, for evaluation of changes in hormones over time. Another group of 83 similar survivors of malignant lymphoma with testosterone in the high end of reference levels were also used for comparison, to identify groups of increased risk of testosterone deficiency. A total group of 143 survivors were therefore included in the study. Our findings indicate that for screening purposes an initial total testosterone is sufficient in some survivors because sexual hormone binding globulin concentration was found stable over time. However, 15% were found with subnormal calculated free testosterone. Survivors intensely treated for Hodgkin lymphoma and older survivors were identified as high-risk groups for testosterone deficiency necessitating endocrinological attention during follow-up. Some evidence of pituitary downregulation was also found, because of uncompensated decreases in testosterone concentration over time. In conclusion, longitudinal measurements of total testosterone alone do not seem adequate for the screening of testosterone deficiency for all long-term lymphoma survivors.

Outcome data of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) beyond the second line are scarce outside of clinical trials. Novel therapies in the R/R setting have been approved based on single-arm trials, but results need to be contextualized by real-world outcomes. Medical records from 3753 Danish adults diagnosed with DLBCL were reviewed. Patients previously treated with rituximab and anthracycline-based chemotherapy who received the third or later line (3 L+) of treatment after 1 January 2015, were included. Only 189 patients with a median age of 71 years were eligible. The median time since the last line of therapy was 6 months. Patients were treated with either best supportive care (22%), platinum-based salvage therapy (13%), low-intensity chemotherapy (22%), in clinical trial (14%) or various combination treatments (32%). The 2-year OS-/PFS estimates were 25% and 12% for all patients and 49% and 17% for those treated with platinum-based salvage therapy. Age ≥70, CNS involvement, elevated LDH and ECOG ≥2 predicted poor outcomes, and patients with 0–1 of these risk factors had a 2-year OS estimate of 65%. Only a very small fraction of DLBCL patients received third-line treatment and were eligible for inclusion. Outcomes were generally poor, but better in intensively treated, fit young patients with limited disease., Outcome data of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) beyond the second line are scarce outside of clinical trials. Novel therapies in the R/R setting have been approved based on single-arm trials, but results need to be contextualized by real-world outcomes. Medical records from 3753 Danish adults diagnosed with DLBCL were reviewed. Patients previously treated with rituximab and anthracycline-based chemotherapy who received the third or later line (3 L+) of treatment after 1 January 2015, were included. Only 189 patients with a median age of 71 years were eligible. The median time since the last line of therapy was 6 months. Patients were treated with either best supportive care (22%), platinum-based salvage therapy (13%), low-intensity chemotherapy (22%), in clinical trial (14%) or various combination treatments (32%). The 2-year OS-/PFS estimates were 25% and 12% for all patients and 49% and 17% for those treated with platinum-based salvage therapy. Age ≥70, CNS involvement, elevated LDH and ECOG ≥2 predicted poor outcomes, and patients with 0–1 of these risk factors had a 2-year OS estimate of 65%. Only a very small fraction of DLBCL patients received third-line treatment and were eligible for inclusion. Outcomes were generally poor, but better in intensively treated, fit young patients with limited disease.

Cardiovascular diseases, especially congestive heart failure (CHF), are known complications of anthracyclines, but the risk for patients undergoing high-dose chemotherapy and autologous stem cell transplant (HDT-ASCT) is not well established. With T-cell therapies emerging as alternatives, studies of long-term complications after HDT-ASCT are warranted. Danish patients treated with HDT-ASCT for aggressive lymphoma between 2001 and 2017 were matched 1:5 on sex, birth year and Charlson comorbidity score to the general population. Events were captured using nationwide registers. A total of 787 patients treated with HDT-ASCT were identified. Median follow-up was 7.6 years. The risk of CHF was significantly increased in the HDT-ASCT population compared to matched comparators with an adjusted hazard ratio (HR) of 5.5 (3.8–8.1). The 10-year cumulative incidence of CHF was 8.0% versus 2.0% (p < 0.001). Male sex, ≥2 lines of therapy, hypertension and cumulative anthracycline dose (≥300 mg/m2) were risk factors for CHF. In a separate cohort of 4089 lymphoma patients, HDT-ASCT was also significantly associated with increased risk of CHF (adjusted HR of 2.6 [1.8–3.8]) when analysed as a time-dependent exposure. HDT-ASCT also increased the risk of other cardiac diseases. These findings are applicable for the benefit/risk assessment of HDT-ASCT versus novel therapies.

Introduction Treatment of lymphoma can be associated with cognitive challenges, and some patients may fear development of dementia as long-term complication. Studies report a lower risk of dementia after cancer. Some believe this difference to be a protective mechanism of cancer, others believe it to be driven by bias. The risk of developing dementia after lymphoma has not been investigated in a population-based setting. The aim of this study was to identify the risk of being diagnosed with dementia after lymphoma treatment. Materials and Methods This Danish nationwide matched cohort study included patients aged ≥65 years with a first-time diagnosis of a non-central nervous system lymphoma between 2005 and 2018 in complete remission after treatment with chemotherapy. Patients diagnosed with dementia or treated with dementia medication before lymphoma diagnosis were excluded. Each patient was matched 1:5 on sex, year of birth, and a modified Charlson comorbidity index. Patients and matched comparators were followed from the corresponding patient's date of complete remission. The risk of developing dementia was calculated using cause-specific hazard ratios (HR), and the cumulative risk was estimated by Aalen-Johansen with death as the competing risk. Results A total of 3,244 patients and 16,220 matched comparators were included in the study. There was no difference in risk of all-cause dementia among patients with lymphoma compared to matched comparators with cause-specific HR of 0.85 (95% confidence interval [CI]: 0.70;1.04). The risk of both Alzheimer's disease and non-Alzheimer's dementia was equal among patients and comparators: HR 0.89 (95% CI: 0.66;1.21) and 0.82 (95% CI: 0.63;1.07), respectively. Stratified by lymphoma subtype, age, or year of diagnosis, the risk of all-cause dementia remained equal among patients and matched comparators. The cumulative risk of all-cause dementia was significantly lower among patients with lymphoma, Introduction: Treatment of lymphoma can be associated with cognitive challenges, and some patients may fear development of dementia as long-term complication. Studies report a lower risk of dementia after cancer. Some believe this difference to be a protective mechanism of cancer, others believe it to be driven by bias. The risk of developing dementia after lymphoma has not been investigated in a population-based setting. The aim of this study was to identify the risk of being diagnosed with dementia after lymphoma treatment. Materials and Methods: This Danish nationwide matched cohort study included patients aged ≥65 years with a first-time diagnosis of a non-central nervous system lymphoma between 2005 and 2018 in complete remission after treatment with chemotherapy. Patients diagnosed with dementia or treated with dementia medication before lymphoma diagnosis were excluded. Each patient was matched 1:5 on sex, year of birth, and a modified Charlson comorbidity index. Patients and matched comparators were followed from the corresponding patient's date of complete remission. The risk of developing dementia was calculated using cause-specific hazard ratios (HR), and the cumulative risk was estimated by Aalen-Johansen with death as the competing risk. Results: A total of 3,244 patients and 16,220 matched comparators were included in the study. There was no difference in risk of all-cause dementia among patients with lymphoma compared to matched comparators with cause-specific HR of 0.85 (95% confidence interval [CI]: 0.70;1.04). The risk of both Alzheimer's disease and non-Alzheimer's dementia was equal among patients and comparators: HR 0.89 (95% CI: 0.66;1.21) and 0.82 (95% CI: 0.63;1.07), respectively. Stratified by lymphoma subtype, age, or year of diagnosis, the risk of all-cause dementia remained equal among patients and matched comparators. The cumulative risk of all-cause dementia was significantly lower among patients with lymphoma compared to matched com

In the current study, we report the prevalence of male testosterone deficiency in a cohort of 60 male long-term survivors of malignant lymphoma with normal total testosterone but in the lower part of the reference level. Testosterone deficiency was defined as subnormal concentrations of total testosterone or subnormal concentrations of calculated free testosterone. The aim was to clarify whether total testosterone was sufficient for identification of testosterone deficiency in male survivors of malignant lymphoma. Hormonal analyses taken at follow-up were compared with samples taken at diagnosis for a subgroup of 20 survivors, for evaluation of changes in hormones over time. Another group of 83 similar survivors of malignant lymphoma with testosterone in the high end of reference levels were also used for comparison, to identify groups of increased risk of testosterone deficiency. A total group of 143 survivors were therefore included in the study. Our findings indicate that for screening purposes an initial total testosterone is sufficient in some survivors because sexual hormone binding globulin concentration was found stable over time. However, 15% were found with subnormal calculated free testosterone. Survivors intensely treated for Hodgkin lymphoma and older survivors were identified as high-risk groups for testosterone deficiency necessitating endocrinological attention during follow-up. Some evidence of pituitary downregulation was also found, because of uncompensated decreases in testosterone concentration over time. In conclusion, longitudinal measurements of total testosterone alone do not seem adequate for the screening of testosterone deficiency for all long-term lymphoma survivors., In the current study, we report the prevalence of male testosterone deficiency in a cohort of 60 male long-term survivors of malignant lymphoma with normal total testosterone but in the lower part of the reference level. Testosterone deficiency was defined as subnormal concentrations of total testosterone or subnormal concentrations of calculated free testosterone. The aim was to clarify whether total testosterone was sufficient for identification of testosterone deficiency in male survivors of malignant lymphoma. Hormonal analyses taken at follow-up were compared with samples taken at diagnosis for a subgroup of 20 survivors, for evaluation of changes in hormones over time. Another group of 83 similar survivors of malignant lymphoma with testosterone in the high end of reference levels were also used for comparison, to identify groups of increased risk of testosterone deficiency. A total group of 143 survivors were therefore included in the study. Our findings indicate that for screening purposes an initial total testosterone is sufficient in some survivors because sexual hormone binding globulin concentration was found stable over time. However, 15% were found with subnormal calculated free testosterone. Survivors intensely treated for Hodgkin lymphoma and older survivors were identified as high-risk groups for testosterone deficiency necessitating endocrinological attention during follow-up. Some evidence of pituitary downregulation was also found, because of uncompensated decreases in testosterone concentration over time. In conclusion, longitudinal measurements of total testosterone alone do not seem adequate for the screening of testosterone deficiency for all long-term lymphoma survivors.

The Hunga Tonga–Hunga Ha′apai volcano erupted on 15 January 2022, launching Lamb waves and gravity waves into the atmosphere. In this study, we present results using 13 globally distributed meteor radars and identify the volcanogenic gravity waves in the mesospheric/lower thermospheric winds. Leveraging the High-Altitude Mechanistic general Circulation Model (HIAMCM), we compare the global propagation of these gravity waves. We observed an eastward-propagating gravity wave packet with an observed phase speed of 240 ± 5.7 m s−1 and a westward-propagating gravity wave with an observed phase speed of 166.5 ± 6.4 m s−1. We identified these waves in HIAMCM and obtained very good agreement of the observed phase speeds of 239.5 ± 4.3 and 162.2 ± 6.1 m s−1 for the eastward the westward waves, respectively. Considering that HIAMCM perturbations in the mesosphere/lower thermosphere were the result of the secondary waves generated by the dissipation of the primary gravity waves from the volcanic eruption, this affirms the importance of higher-order wave generation. Furthermore, based on meteor radar observations of the gravity wave propagation around the globe, we estimate the eruption time to be within 6 min of the nominal value of 15 January 2022 04:15 UTC, and we localized the volcanic eruption to be within 78 km relative to the World Geodetic System 84 coordinates of the volcano, confirming our estimates to be realistic.

The Global Ocean Data Analysis Project (GLODAP) is a synthesis effort providing regular compilations of surface to bottom ocean biogeochemical bottle data, with an emphasis on seawater inorganic carbon chemistry and related variables determined through chemical analysis of seawater samples. GLODAPv2.2023 is an update of the previous version, GLODAPv2.2022 (Lauvset et al., 2022). The major changes are as follows: data from 23 new cruises were added. In addition, a number of changes were made to the data included in GLODAPv2.2022. GLODAPv2.2023 includes measurements from more than 1.4 million water samples from the global oceans collected on 1108 cruises. The data for the now 13 GLODAP core variables (salinity, oxygen, nitrate, silicate, phosphate, dissolved inorganic carbon, total alkalinity, pH, chlorofluorocarbon-11 (CFC-11), CFC-12, CFC-113, CCl4, and SF6) have undergone extensive quality control with a focus on the systematic evaluation of bias. The data are available in two formats: (i) as submitted by the data originator but converted to World Ocean Circulation Experiment (WOCE) exchange format and (ii) as a merged data product with adjustments applied to minimize bias. For the present annual update, adjustments for the 23 new cruises were derived by comparing those data with the data from the 1085 quality-controlled cruises in the GLODAPv2.2022 data product using crossover analysis. SF6 data from all cruises were evaluated by comparison with CFC-12 data measured on the same cruises. For nutrients and ocean carbon dioxide (CO2), chemistry comparisons to estimates based on empirical algorithms provided additional context for adjustment decisions. The adjustments that we applied are intended to remove potential biases from errors related to measurement, calibration, and data-handling practices without removing known or likely time trends or variations in the variables evaluated. The compiled and adjusted data product is believed to be consistent to better than 0.

Some of the highest rates of primary production across the Southern Ocean occur in the seasonal ice zone (SIZ), making this a prominent area of importance for both local ecosystems and the global carbon cycle. There, the annual advance and retreat of ice impacts light and nutrient availability, as well as the circulation and stratification, thereby imposing a dominant control on phytoplankton growth. In this study, the drivers of variability in phytoplankton growth between 2002–2020 in the Weddell Gyre SIZ were assessed using satellite net primary production (NPP) products alongside chlorophyll-a and particulate organic carbon (POC) data from autonomous biogeochemical floats. Although the highest daily rates of NPP are consistently observed in the continental shelf region (water depths shallower than 2000 m), the open-ocean region's larger size and longer ice-free season mean that it dominates biological carbon uptake within the Weddell Gyre, accounting for 93 %–96 % of the basin's total annual NPP. Variability in the summer maximum ice-free area is the strongest predictor of inter-annual variability in total NPP across the Weddell Gyre, with greater ice-free area resulting in greater annual NPP, explaining nearly half of the variance (R2=42 %). In the shelf region, the return of sea ice cover controls the end of the productive season. In the open ocean, however, both satellite NPP and float data show that a decline in NPP occurs before the end of the ice-free season (∼ 80 to 130 d after sea ice retreat). Evidence of concurrent increases in float-observed chlorophyll-a and POC suggest that later in the summer season additional factors such as micro-nutrient availability or top-down controls (e.g. grazing) could be limiting NPP. These results indicate that in a warmer and more ice-free Weddell Gyre, notwithstanding compensating changes in nutrient supply, NPP is likely to be enhanced only up to a certain limit of ice-free days.

Eva Futtrup Maksten,1,2 Lasse Hjort Jakobsen,1,3 Kristian Hay Kragholm,4 Joachim Baech,1,2 Mikkel Porsborg Andersen,5 Jakob Madsen,1,2 Judit Mészáros Jørgensen,6 Michael Roost Clausen,7 Robert Schou Pedersen,8 Andriette Dessau-Arp,9 Thomas Stauffer Larsen,10 Christian Bjørn Poulsen,11 Anne Ortved Gang,12 Peter Brown,12 Kirsten Fonager,2,13 Tarec C El-Galaly,1,2 Marianne Tang Severinsen1,2 1Department of Haematology, Clinical Cancer Research Unit, Aalborg University Hospital, Aalborg, Denmark; 2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 3Department Mathematical Sciences, Aalborg University, Aalborg, Denmark; 4Department of Cardiology & Unit of Epidemiology and Biostatistics, Aalborg University Hospital, Aalborg, Denmark; 5Department of Cardiology, Nordsjaellands Hospital, Hillerød, Denmark; 6Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; 7Department of Haematology, Vejle Hospital, Vejle, Denmark; 8Department of Medicine, Section of Haematology, Regionshospital Goedstrup, Goedstrup, Denmark; 9Department of Haematology, Hospital South West Jutland, Esbjerg, Denmark; 10Department of Haematology, Odense University Hospital, Odense, Denmark; 11Department of Haematology, Zealand University Hospital, Roskilde, Denmark; 12Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 13Department of Social Medicine, Aalborg University Hospital, Aalborg, DenmarkCorrespondence: Eva Futtrup Maksten, Department of Haematology, Clinical Cancer Research Unit, Aalborg University Hospital, Sdr. Skovvej 15, Aalborg, 9000, Denmark, Tel +45 97663872, Fax + 45 97666323, Email efm@rn.dkPurpose: Many patients diagnosed with lymphoma are of working age. Cancer patients are known to have a higher risk of sick leave and disability pension, but this has only been delineated for certain subtypes of lymphoma. Therefore, this stu

When discovered, SN 2017egm was the closest (redshift z = 0.03) hydrogen-poor superluminous supernova (SLSN-I) and a rare case that exploded in a massive and metal-rich galaxy. Thus, it has since been extensively observed and studied. We report spectroscopic data showing strong emission at around He i lambda 10830 and four He i absorption lines in the optical. Consequently, we classify SN 2017egm as a member of an emerging population of helium-rich SLSNe-I (i.e., SLSNe-Ib). We also present our late-time photometric observations. By combining them with archival data, we analyze high-cadence ultraviolet, optical, and near-infrared light curves spanning from early pre-peak (similar to-20 days) to late phases (similar to+300 days). We obtain its most complete bolometric light curve, in which multiple bumps are identified. None of the previously proposed models can satisfactorily explain all main light-curve features, while multiple interactions between the ejecta and circumstellar material (CSM) may explain the undulating features. The prominent infrared excess with a blackbody luminosity of 10(7)-10(8) L (circle dot) detected in SN 2017egm could originate from the emission of either an echo of a pre-existing dust shell or newly formed dust, offering an additional piece of evidence supporting the ejecta-CSM interaction model. Moreover, our analysis of deep Chandra observations yields the tightest-ever constraint on the X-ray emission of an SLSN-I, amounting to an X-ray-to-optical luminosity ratio less than or similar to 10(-3) at late phases (similar to 100-200 days), which could help explore its close environment and central engine.

Bioblitzes are a popular approach to engage people and collect biodiversity data. Despite this, few studies have actually evaluated the multiple outcomes of bioblitz activities. We used a systematic review, an analysis of data from more than 1000 bioblitzes, and a detailed analysis of one specific bioblitz to inform our inquiry. We evaluated five possible bioblitz outcomes, which were creating a species inventory, engaging people in biological recording, enhancing learning about nature, discovering a species new to an area, and promoting an organization. We conclude that bioblitzes are diverse but overall effective at their aims and have advantages over unstructured biodiversity recording. We demonstrate for the first time that bioblitzes increase the recording activity of the participants for several months after the event. In addition, we provide evidence that bioblitzes are effective at bringing people and organizations together to build communities of professionals and amateurs, critical for conserving and protecting biodiversity.

Background: Many cancer survivors experience late effects after cancer. Comorbidity, health literacy, late effects, and help-seeking behavior may affect healthcare use and may differ among socioeconomic groups. We examined healthcare use among cancer survivors, compared with cancer-free individuals, and investigated educational differences in healthcare use among cancer survivors. Methods: A Danish cohort of 127,472 breast, prostate, lung, and colon cancer survivors from the national cancer databases, and 637,258 age- and sex-matched cancer-free individuals was established. Date of entry was 12 months after diagnosis/index date (for cancer-free individuals). Follow-up ended at death, emigration, new primary cancer, December 31st, 2018, or up to 10 years. Information about education and healthcare use, defined as the number of consultations with general practitioner (GP), private practicing specialists (PPS), hospital, and acute healthcare contacts 1–9 years after diagnosis/index date, was extracted from national registers. We used Poisson regression models to compare healthcare use between cancer survivors and cancer-free individuals, and to investigate the association between education and healthcare use among cancer survivors. Results: Cancer survivors had more GP, hospital, and acute healthcare contacts than cancer-free individuals, while the use of PPS were alike. One-to-four-year survivors with short compared to long education had more GP consultations (breast, rate ratios (RR) = 1.28, 95% CI = 1.25–1.30; prostate, RR = 1.14, 95% CI = 1.10–1.18; lung, RR = 1.18, 95% CI = 1.13–1.23; and colon cancer, RR = 1.17, 95% CI = 1.13–1.22) and acute contacts (breast, RR = 1.35, 95% CI = 1.26–1.45; prostate, RR = 1.26, 95% CI = 1.15–1.38; lung, RR = 1.24, 95% CI = 1.16–1.33; and colon cancer, RR = 1.35, 95% CI = 1.14–1.60), even after adjusting for comorbidity. One-to-four-year survivors with short compared to long education had less consultations with PPS, while no as

Purpose: Many patients diagnosed with lymphoma are of working age. Cancer patients are known to have a higher risk of sick leave and disability pension, but this has only been delineated for certain subtypes of lymphoma. Therefore, this study aimed at investigating the overall risk of disability pension for all lymphoma subtypes and at quantifying return to work for patients with lymphoma in work before diagnosis. Patients and Methods: Patients aged 18– 60 years with lymphoma in complete remission (CR) diagnosed between 2000 and 2019 were included in the study. Using national registers, each patient was matched with five comparators from the general population with same sex, birth year, and level of Charlson Comorbidity Index. Risk of disability pension was calculated from 90 days after CR or end of treatment with competing events (death, retirement pension, early retirement pension, relapse for patients, or lymphoma diagnosis for comparators). Return to work for patients was calculated annually until 5 years after diagnosis for patients employed before diagnosis. Results: In total, 4072 patients and 20,360 comparators were included. There was a significant increased risk of disability pension for patients with all types of lymphoma compared to the general population (5-year risk difference: 5.3 (95% confidence interval (CI): 4.4;6.2)). Patients with non-Hodgkin lymphoma were more likely to get disability pension than patients with Hodgkin lymphoma (sex- and age-adjusted 10-year risk difference: 2.9 (95% CI: 0.3;5.5)). One year after diagnosis, 24.5% of the relapse-free patients were on sick leave. Return to work was highest 2 years after diagnosis (82.1%). Conclusion: Patients with lymphoma across all subtypes have a significantly higher risk of disability pension. Return to work peaks at 2 years after diagnosis., Purpose: Many patients diagnosed with lymphoma are of working age. Cancer patients are known to have a higher risk of sick leave and disability pension, but this has only been delineated for certain subtypes of lymphoma. Therefore, this study aimed at investigating the overall risk of disability pension for all lymphoma subtypes and at quantifying return to work for patients with lymphoma in work before diagnosis. Patients and Methods: Patients aged 18–60 years with lymphoma in complete remission (CR) diagnosed between 2000 and 2019 were included in the study. Using national registers, each patient was matched with five comparators from the general population with same sex, birth year, and level of Charlson Comorbidity Index. Risk of disability pension was calculated from 90 days after CR or end of treatment with competing events (death, retirement pension, early retirement pension, relapse for patients, or lymphoma diagnosis for comparators). Return to work for patients was calculated annually until 5 years after diagnosis for patients employed before diagnosis. Results: In total, 4072 patients and 20,360 comparators were included. There was a significant increased risk of disability pension for patients with all types of lymphoma compared to the general population (5-year risk difference: 5.3 (95% confidence interval (CI): 4.4;6.2)). Patients with non-Hodgkin lymphoma were more likely to get disability pension than patients with Hodgkin lymphoma (sex-and age-adjusted 10-year risk difference: 2.9 (95% CI: 0.3;5.5)). One year after diagnosis, 24.5% of the relapse-free patients were on sick leave. Return to work was highest 2 years after diagnosis (82.1%). Conclusion: Patients with lymphoma across all subtypes have a significantly higher risk of disability pension. Return to work peaks at 2 years after diagnosis.

18 mm-sized Orionid meteoroids were captured in 2019 and 2020 by the Canadian Automated Observatory's mirror tracking system. Meteor position measurements were made to an accuracy of $\sim1$ m and the meteors were tracked to a limiting magnitude of about $+7.5$ at the faintest point. The trajectory estimation shows the intrinsic physical dispersion of the Orionid radiant is $0.400^{\circ} \pm 0.062^{\circ}$. An erosion-based entry model was fit to the observations to reproduce ablation and fragmentation for each meteor, simultaneously reproducing the light curve, the dynamics, and the wake. Wake observations were found to directly inform the grain mass distribution released in the modelled erosion. A new luminous efficiency model was derived from simultaneous radar and optical observations and applied in the modelling to improve its accuracy. The results show that the apparent strength of Orionids varies with radiant location and time of appearance during the period of shower activity. The average differential grain mass distribution index was 2.15, higher than found from in-situ estimates, possibly due to the evolution of the physical properties of meteoroids since ejection. All Orionids showed leading fragment morphology which was best explained by stopping the erosion at the peak of the light curve, leaving a non-fragmenting meteoroid with $\sim10\%$ of the original mass. The inverted Orionid meteoroid average bulk density of $\sim300$ kg m$^{-3}$, corresponding to porosities of $\sim90\%$, is consistent with in-situ measurements of larger dust particles by Vega-2 at 1P/Halley and Rosetta at 67P., Comment: Accepted for publication in Icarus

We present a comprehensive data set of supernova (SN) 2016adj located within the central dust lane of Centaurus A. SN 2016adj is significantly reddened and after correcting the peak apparent $B$-band magnitude ($m_B = 17.48\pm0.05$) for Milky Way reddening and our inferred host-galaxy reddening parameters (i.e., $R_{V}^{host} = 5.7\pm0.7$ and $A_{V}^{host} = 6.3\pm0.2$), we estimate it reached a peak absolute magnitude of $M_B \sim -18$. Detailed inspection of the optical/NIR spectroscopic time-series reveals a carbon-rich SN Ic and not a SN Ib/IIb as previously suggested in the literature. The NIR spectra shows prevalent carbon-monoxide formation occurring already by +41 days past $B$-band maximum, which is $\approx 11$ days earlier than previously reported in the literature for this object. Interestingly around two months past maximum, the NIR spectrum of SN~2016adj begins to exhibit H features, with a +97~d medium resolution spectrum revealing both Paschen and Bracket lines with absorption minima of $\sim 2000$ km/s, full-width-half-maximum emission velocities of $\sim 1000$ km/s, and emission line ratios consistent with a dense emission region. We speculate these attributes are due to circumstellar interaction (CSI) between the rapidly expanding SN ejecta and a H-rich shell of material formed during the pre-SN phase. A bolometric light curve is constructed and a semi-analytical model fit suggests the supernova synthesized 0.5 solar masses of $^{56}$Ni and ejected 4.2 solar masses of material, though these values should be approached with caution given the large uncertainties associated with the adopted reddening parameters, possible CSI contamination, and known light echo emission. Finally, inspection of Hubble Space Telescope archival data yielded no progenitor detection., Comment: Submitted to A&A, comments are welcome

We present an analysis of Type Ia Supernovae (SNe~Ia) from both the Carnegie Supernova Project~I (CSP-I) and II (CSP-II), and extend the Hubble diagram from the optical to the near-infrared wavelengths ($uBgVriYJH$). We calculate the Hubble constant, $H_0$, using various distance calibrators: Cepheids, Tip of the Red Giant Branch (TRGB), and Surface Brightness Fluctuations (SBF). Combining all methods of calibrations, we derive $\rm H_0=71.76 \pm 0.58 \ (stat) \pm 1.19 \ (sys) \ km \ s^{-1} \ Mpc^{-1}$ from $B$-band, and $\rm H_0=73.22 \pm 0.68 \ (stat) \pm 1.28 \ (sys) \ km \ s^{-1} \ Mpc^{-1}$ from $H$-band. By assigning equal weight to the Cepheid, TRGB, and SBF calibrators, we derive the systematic errors required for consistency in the first rung of the distance ladder, resulting in a systematic error of $1.2\sim 1.3 \rm \ km \ s^{-1} \ Mpc^{-1}$ in $H_0$. As a result, relative to the statistics-only uncertainty, the tension between the late-time $H_0$ we derive by combining the various distance calibrators and the early-time $H_0$ from the Cosmic Microwave Background is reduced. The highest precision in SN~Ia luminosity is found in the $Y$ band ($0.12\pm0.01$ mag), as defined by the intrinsic scatter ($\sigma_{int}$). We revisit SN~Ia Hubble residual-host mass correlations and recover previous results that these correlations do not change significantly between the optical and the near-infrared wavelengths. Finally, SNe~Ia that explode beyond 10 kpc from their host centers exhibit smaller dispersion in their luminosity, confirming our earlier findings. Reduced effect of dust in the outskirt of hosts may be responsible for this effect., Comment: Revised calculations are made. Will be resubmitted to ApJ

We present the discovery of the Type II supernova SN 2023ixf in M101 and follow-up photometric and spectroscopic observations, respectively, in the first month and week of its evolution. Our discovery was made within a day of estimated first light, and the following light curve is characterized by a rapid rise ($\approx5$ days) to a luminous peak ($M_V\approx-18.2$ mag) and plateau ($M_V\approx-17.6$ mag) extending to $30$ days with a fast decline rate of $\approx0.03$ mag day$^{-1}$. During the rising phase, $U-V$ color shows blueward evolution, followed by redward evolution in the plateau phase. Prominent flash features of hydrogen, helium, carbon, and nitrogen dominate the spectra up to $\approx5$ days after first light, with a transition to a higher ionization state in the first $\approx2$ days. Both the $U-V$ color and flash ionization states suggest a rise in the temperature, indicative of a delayed shock breakout inside dense circumstellar material (CSM). From the timescales of CSM interaction, we estimate its compact radial extent of $\sim(3-7)\times10^{14}$ cm. We then construct numerical light-curve models based on both continuous and eruptive mass-loss scenarios shortly before explosion. For the continuous mass-loss scenario, we infer a range of mass-loss history with $0.1-1.0\,M_\odot\,{\rm yr}^{-1}$ in the final $2-1$ yr before explosion, with a potentially decreasing mass loss of $0.01-0.1\,M_\odot\,{\rm yr}^{-1}$ in $\sim0.7-0.4$ yr toward the explosion. For the eruptive mass-loss scenario, we favor eruptions releasing $0.3-1\,M_\odot$ of the envelope at about a year before explosion, which result in CSM with mass and extent similar to the continuous scenario. We discuss the implications of the available multiwavelength constraints obtained thus far on the progenitor candidate and SN 2023ixf to our variable CSM models., Comment: Updated to match the published letter in ApJL, 2023 September 19

A critical review of the evidence for the interstellar origin for the USG 20140108 fireball is presented. Examining USG fireball velocities where independent data are available shows the former to have significant (10-15 km/s) uncertainties at large speeds and highly variable radiant accuracy, with average errors in excess of ten degrees. Ablation model fits to the observed lightcurve are possible for normal chondritic impactors only assuming low speeds. To match the high speed and low fragmentation height of the USG 20140108 fireball would require a high density/strength object with low drag and highly aerodynamic shape not made of iron. We suggest the simpliest explanation for the unusual characteristics of USG 20140108 is that the speed, in particular, is substantially overestimated., Comment: Accepted for publication in ApJ; 24 pages, 6 figures

We present the densely sampled early light curve of the Type II supernova (SN) 2023ixf, first observed within hours of explosion in the nearby Pinwheel Galaxy (Messier 101; 6.7 Mpc). Comparing these data to recently updated models of shock-cooling emission, we find that the progenitor likely had a radius of $410 \pm 10\ R_\odot$. Our estimate is model dependent but consistent with a red supergiant. These models provide a good fit to the data starting about 1 day after the explosion, despite the fact that the classification spectrum shows signatures of circumstellar material around SN 2023ixf during that time. Photometry during the first day after the explosion, provided almost entirely by amateur astronomers, does not agree with the shock-cooling models or a simple power-law rise fit to data after 1 day. We consider the possible causes of this discrepancy, including precursor activity from the progenitor star, circumstellar interaction, and emission from the shock before or after it breaks out of the stellar surface. The very low luminosity ($-11\mathrm{\ mag} > M > -14\mathrm{\ mag}$) and short duration of the initial excess lead us to prefer a scenario related to prolonged emission from the SN shock traveling through the progenitor system., Comment: updated to match accepted version

A growing number of supernovae (SNe) are now known to exhibit evidence for significant interaction with a dense, pre-existing, circumstellar medium (CSM). SNe Ibn comprise one such class that can be characterised by both rapidly evolving light curves and persistent narrow He I lines. The origin of such a dense CSM in these systems remains a pressing question, specifically concerning the progenitor system and mass-loss mechanism. In this paper, we present multi-wavelength data of the Type Ibn SN 2020nxt, including $HST$/STIS ultraviolet spectra. We fit the data with recently updated CMFGEN models designed to handle configurations for SNe Ibn. The UV coverage yields strong constraints on the energetics and, when combined with the CMFGEN models, offer new insight on potential progenitor systems. We find the most successful model is a $\lesssim4 {\rm M}_\odot$ helium star that lost its $\sim 1\,{\rm M}_\odot$ He-rich envelope in the years preceding core collapse. We also consider viable alternatives, such as a He white dwarf merger. Ultimately, we conclude at least some SNe Ibn do not arise from single, massive ($>30 {\rm M}_\odot$) Wolf-Rayet-like stars., Comment: 17 pages, 13 figures, 1 table, submitted to MNRAS

We present five far- and near-ultraviolet spectra of the Type II plateau supernova, SN 2022acko, obtained 5, 6, 7, 19, and 21 days after explosion, all observed with the Hubble Space Telescope/Space Telescope Imaging Spectrograph. The first three epochs are earlier than any Type II plateau supernova has been observed in the far-ultraviolet revealing unprecedented characteristics. These three spectra are dominated by strong lines, primarily from metals, which contrasts with the relatively featureless early optical spectra. The flux decreases over the initial time series as the ejecta cools and line-blanketing takes effect. We model this unique dataset with the non-local thermodynamic equilibrium radiation transport code CMFGEN, finding a good match to the explosion of a low mass red supergiant with energy Ekin = 6 x 10^50 erg. With these models we identify, for the first time, the ions that dominate the early UV spectra. We also present optical photometry and spectroscopy, showing that SN 2022acko has a peak absolute magnitude of V = -15.4 mag and plateau length of ~115d. The spectra closely resemble those of SN 2005cs and SN 2012A. Using the combined optical and UV spectra, we report the fraction of flux redwards of the uvw2, U, B, and V filters on days 5, 7, and 19. We also create a spectral time-series of Type II supernovae in the ultraviolet, demonstrating the rapid decline of UV flux over the first few weeks of evolution. Future observations of Type II supernovae will continue to explore the diversity seen in the limited set of high-quality UV spectra., Comment: Published in ApJL

Superluminous supernovae are among the most energetic stellar explosions in the Universe, but their energy sources remain an open question. Here we present long-term observations of one of the closest examples of the hydrogen-poor subclass (SLSNe-I), SN~2017egm, revealing the most complicated known luminosity evolution of SLSNe-I. Three distinct post-peak bumps were recorded in its light curve collected at about $100$--350\,days after maximum brightness, challenging current popular power models such as magnetar, fallback accretion, and interaction between ejecta and a circumstellar shell. However, the complex light curve can be well modelled by successive interactions with multiple circumstellar shells with a total mass of about $6.8$--7.7\,M$_\odot$. In this scenario, large energy deposition from interaction-induced reverse shocks results in ionization of neutral oxygen in the supernova ejecta and hence a much lower nebular-phase line ratio of [O\,\textsc{i}] $\lambda6300$/([Ca\,\textsc{ii}] + [O\,\textsc{ii}]) $\lambda7300$ ($\sim 0.2$) compared with that derived for other superluminous and normal stripped-envelope SNe. The pre-existing multiple shells indicate that the progenitor of SN~2017egm experienced pulsational mass ejections triggered by pair instability within 2 years before explosion, in robust agreement with theoretical predictions for a pre-pulsation helium-core mass of 48--51\,M$_{\odot}$. Finally, this work shows that the final explosion product may be a black hole with about 40\,M$_{\odot}$, and has significant implication for the formation of such heavy black holes that have been recently observed by LIGO-Virgo gravitational wave detectors., Comment: 34 pages, 13 figures, 6 tables

We report early-time ultraviolet (UV) and optical spectroscopy of the young, nearby Type II supernova (SN) 2022wsp obtained by the Hubble Space Telescope (HST)/STIS at about 10 and 20 days after the explosion. The SN 2022wsp UV spectra are compared to those of other well-observed Type II/IIP SNe, including the recently studied Type IIP SN 2021yja. Both SNe exhibit rapid cooling and similar evolution during early phases, indicating a common behavior among SNe II. Radiative-transfer modeling of the spectra of SN 2022wsp with the TARDIS code indicates a steep radial density profile in the outer layer of the ejecta, a supersolar metallicity, and a relatively high total extinction of E(B-V) = 0.35 mag. The early-time evolution of the photospheric velocity and temperature derived from the modeling agree with the behavior observed from other previously studied cases. The strong suppression of hydrogen Balmer lines in the spectra suggests interaction with a pre-existing circumstellar environment could be occurring at early times. In the SN 2022wsp spectra, the absorption component of the Mg II P Cygni profile displays a double-trough feature on day +10 that disappears by day +20. The shape is well reproduced by the model without fine-tuning the parameters, suggesting that the secondary blueward dip is a metal transition that originates in the SN ejecta., Comment: Submitted to ApJ Letters on 4/11/2023

We present photometric and spectroscopic observations and analysis of SN 2021bxu (ATLAS21dov), a low-luminosity, fast-evolving Type IIb supernova (SN). SN 2021bxu is unique, showing a large initial decline in brightness followed by a short plateau phase. With $M_r = -15.93 \pm 0.16\, \mathrm{mag}$ during the plateau, it is at the lower end of the luminosity distribution of stripped-envelope supernovae (SE-SNe) and shows a distinct $\sim$10 day plateau not caused by H- or He-recombination. SN 2021bxu shows line velocities which are at least $\sim1500\,\mathrm{km\,s^{-1}}$ slower than typical SE-SNe. It is photometrically and spectroscopically similar to Type IIb SNe during the photospheric phases of evolution, with similarities to Ca-rich IIb SNe. We find that the bolometric light curve is best described by a composite model of shock interaction between the ejecta and an envelope of extended material, combined with a typical SN IIb powered by the radioactive decay of $^{56}$Ni. The best-fit parameters for SN 2021bxu include a $^{56}$Ni mass of $M_{\mathrm{Ni}} = 0.029^{+0.004}_{-0.005}\,\mathrm{M_{\odot}}$, an ejecta mass of $M_{\mathrm{ej}} = 0.61^{+0.06}_{-0.05}\,\mathrm{M_{\odot}}$, and an ejecta kinetic energy of $K_{\mathrm{ej}} = 8.8^{+1.1}_{-1.0} \times 10^{49}\, \mathrm{erg}$. From the fits to the properties of the extended material of Ca-rich IIb SNe we find a trend of decreasing envelope radius with increasing envelope mass. SN 2021bxu has $M_{\mathrm{Ni}}$ on the low end compared to SE-SNe and Ca-rich SNe in the literature, demonstrating that SN 2021bxu-like events are rare explosions in extreme areas of parameter space. The progenitor of SN 2021bxu is likely a low mass He star with an extended envelope., Comment: 18 pages, 15 figures, accepted to MNRAS

When discovered, SN~2017egm was the closest (redshift $z=0.03$) hydrogen-poor superluminous supernova (SLSN-I) and a rare case that exploded in a massive and metal-rich galaxy. Thus, it has since been extensively observed and studied. We report spectroscopic data showing strong emission at around He~I $\lambda$10,830 and four He~I absorption lines in the optical. Consequently, we classify SN~2017egm as a member of an emerging population of helium-rich SLSNe-I (i.e., SLSNe-Ib). We also present our late-time photometric observations. By combining them with archival data, we analyze high-cadence ultra-violet, optical, and near-infrared light curves spanning from early pre-peak ($\sim -20\,d$) to late phases ($\sim +300\,d$). We obtain its most complete bolometric light curve, in which multiple bumps are identified. None of the previously proposed models can satisfactorily explain all main light-curve features, while multiple interactions between the ejecta and circumstellar material (CSM) may explain the undulating features. The prominent infrared excess with a blackbody luminosity of $10^7$--$10^8\,L_{sun}$ detected in SN~2017egm could originate from the emission of either an echo of a pre-existing dust shell, or newly-formed dust, offering an additional piece of evidence supporting the ejecta-CSM interaction model. Moreover, our analysis of deep $Chandra$ observations yields the tightest-ever constraint on the X-ray emission of an SLSN-I, amounting to an X-ray-to-optical luminosity ratio $\lesssim 10^{-3}$ at late phases ($\sim100-200\,d$), which could help explore its close environment and central engine., Comment: 25 pages, 14 Figures, 4 Tables; accepted for publication in ApJ (Mar. 2023)

The $\tau$-Herculids (IAU shower number #61 TAH) is a minor meteor shower associated with comet 73P/Schwassmann-Wachmann 3, a Jupiter-Family comet that disintegrated into several fragments in 1995. As a consequence of the nucleus break-up, possible increased meteor rates were predicted for 2022. On May 30-31, observation networks around the world reported two distinct peaks of TAH activity, around solar longitudes 69.02{\deg} and 69.42{\deg}. This work examines the encounter conditions of the Earth with meteoroids ejected from 73P during the splitting event and on previous perihelion passages. Numerical simulations suggest that the main peak observed in 2022 was caused by meteoroids ejected from the splitting nucleus with four times the typical cometary gas expansion speed. High-resolution measurements performed with the Canadian Automated Meteor Observatory indicate that these meteoroids are fragile, with estimated bulk densities of 250 kg/m$^3$. In contrast with the main peak, the first TAH activity peak in 2022 is best modelled with trails ejected prior to 1960. We find that ordinary cometary activity could have produced other TAH apparitions observed in the past, including in 1930 and 2017. The extension of our model to future years predicts significant returns of the shower in 2033 and 2049., Comment: Accepted for publication in the Astrophysical Journal (Feb. 3, 2023)

Coral reefs are subject to degradation by multiple environmental stressors which are predicted to intensify. Stress can alter ecosystem composition, with shifts from hard coral to macroalgae dominated reefs often accompanied by an increase in soft corals and sponges. Such changes may alter net ecosystem metabolism and biogeochemistry by shifting the balance between photosynthesis, respiration, calcification and dissolution. We deployed high temporal resolution pH and dissolved oxygen (DO) sensors at four Caribbean reef sites with varying covers of hard and soft corals, sponges and macroalgae. The resultant data indicated that the strength of the “metabolic pulse”, specifically the co-variation in daily pH and DO oscillations, was driven by the net balance of light -dependent and -independent metabolism. pH and DO were positively correlated over the diel cycle at coral dominated sites, suggesting that photosynthesis and respiration were the major controlling processes, and further indicated by agreement with a simple production:respiration model. Whereas, at a site with high macroalgal cover, pH and DO decoupling was observed during daylight hours. This indicates that an unidentified light-driven process altered the expected pH:DO relationship. We hypothesize that this could be mediated by the higher levels of macroalgae, which either stimulated bacterial-mediated carbonate dissolution via the production and release of allelopathic compounds or retained oxygen, evolved during photosynthesis, in the gaseous form in seawater (ebullition). Our work demonstrates that high resolution monitoring of pH and DO provides insight into coral reef biogeochemical functioning and can be key for understanding long-term changes in coral reef metabolism.

Ladybirds (Coleoptera: Coccinellidae) provide services that are critical to food production, and they fulfill an ecological role as a food source for predators. The richness, abundance, and distribution of ladybirds, however, are compromised by many anthropogenic threats. Meanwhile, a lack of knowledge of the conservation status of most species and the factors driving their population dynamics hinders the development and implementation of conservation strategies for ladybirds. We conducted a review of the literature on the ecology, diversity, and conservation of ladybirds to identify their key ecological threats. Ladybird populations are most affected by climate factors, landscape composition, and biological invasions. We suggest mitigating actions for ladybird conservation and recovery. Short-term actions include citizen science programs and education, protective measures for habitat recovery and threatened species, prevention of the introduction of non-native species, and the maintenance and restoration of natural areas and landscape heterogeneity. Mid-term actions involve the analysis of data from monitoring programs and insect collections to disentangle the effect of different threats to ladybird populations, understand habitat use by taxa on which there is limited knowledge, and quantify temporal trends of abundance, diversity, and biomass along a management-intensity gradient. Long-term actions include the development of a worldwide monitoring program based on standardized sampling to fill data gaps, increase explanatory power, streamline analyses, and facilitate global collaborations.

In this study we present the results of a five-year follow-up campaign of the long-lived type IIn supernova SN 2017hcc, found in a spiral dwarf host of near-solar metallicity. The long rise time (57 ± 2 days, ATLAS o band) and high luminosity (peaking at −20.78 ± 0.01 mag in the ATLAS o band) point towards an interaction of massive ejecta with massive and dense circumstellar material (CSM). The evolution of SN 2017hcc is slow, both spectroscopically and photometrically, reminiscent of the long-lived type IIn, SN 2010jl. An infrared (IR) excess was apparent soon after the peak, and blueshifts were noticeable in the Balmer lines starting from a few hundred days, but appeared to be fading by around +1200 d. We posit that an IR light echo from pre-existing dust dominates at early times, with some possible condensation of new dust grains occurring at epochs ≳+800 d.

The Southern Ocean upper-layer freshwater balance exerts a global climatic influence by modulating density stratification and biological productivity, and hence the exchange of heat and carbon between the atmosphere and the ocean interior. It is thus important to understand and quantify the time-varying freshwater inputs, which is challenging from measurements of salinity alone. Here we use seawater oxygen isotopes from samples collected between 2016 and 2021 along a transect spanning the Scotia and northern Weddell Seas to separate the freshwater contributions from sea ice and meteoric sources. The unprecedented retreat of sea ice in 2016 is evidenced as a strong increase in sea ice melt across the northern Weddell Sea, with surface values increasing approximately two percentage points between 2016 and 2018 and column inventories increasing approximately 1 to 2 m. Surface meteoric water concentrations exceeded 4% in early 2021 close to South Georgia due to meltwater from the A68 megaberg; smaller icebergs may influence meteoric water at other times also. Both these inputs highlight the importance of a changing cryosphere for upper-ocean freshening; potential future sea ice retreats and increases in iceberg calving would enhance the impacts of these freshwater sources on the ocean and climate. This article is part of a discussion meeting issue ‘Heat and carbon uptake in the Southern Ocean: the state of the art and future priorities’.

Accurate knowledge of the state of the marine carbon system is essential to constrain global carbon budgets. While analytical techniques for characterizing oceanic carbon chemistry are well established and diverse in approach, global monitoring still suffers from a lack of measurements being made both temporally and spatially. Here, we summarize the state of the art for the analysis of some of the main carbon parameters: total dissolved inorganic carbon, (CT or DIC), pH, and total alkalinity (AT). For each, a brief theoretical approach is followed by a description of technical methodology. All the selected techniques are detailed and explained such that they can be used as standard methods aboard an oceanographic vessel. It is expected that by following the methods described in this chapter, independent researchers should be able to make comparable measurements of carbonate system species and pH

When discovered, SN 2017egm was the closest (redshift z = 0.03) hydrogen-poor superluminous supernova (SLSN-I) and a rare case that exploded in a massive and metal-rich galaxy. Thus, it has since been extensively observed and studied. We report spectroscopic data showing strong emission at around He i lambda 10830 and four He i absorption lines in the optical. Consequently, we classify SN 2017egm as a member of an emerging population of helium-rich SLSNe-I (i.e., SLSNe-Ib). We also present our late-time photometric observations. By combining them with archival data, we analyze high-cadence ultraviolet, optical, and near-infrared light curves spanning from early pre-peak (similar to-20 days) to late phases (similar to+300 days). We obtain its most complete bolometric light curve, in which multiple bumps are identified. None of the previously proposed models can satisfactorily explain all main light-curve features, while multiple interactions between the ejecta and circumstellar material (CSM) may explain the undulating features. The prominent infrared excess with a blackbody luminosity of 10(7)-10(8) L (circle dot) detected in SN 2017egm could originate from the emission of either an echo of a pre-existing dust shell or newly formed dust, offering an additional piece of evidence supporting the ejecta-CSM interaction model. Moreover, our analysis of deep Chandra observations yields the tightest-ever constraint on the X-ray emission of an SLSN-I, amounting to an X-ray-to-optical luminosity ratio less than or similar to 10(-3) at late phases (similar to 100-200 days), which could help explore its close environment and central engine.

Peripheral T-Cell Lymphomas (PTCLs) are rare, aggressive lymphomas with poor outcomes, but limited-stage disease is infrequent and not well-described. This study reports outcomes and prognostic factors in limited-stage nodal PTCLs in a binational population-based setting. Patients were identified from the Danish and Swedish lymphoma registries. Adults diagnosed with limited-stage nodal PTCL (stage I-II) and treated with CHOP(−like) therapy ±radiotherapy between 2000 and 2014 were included. Medical records were reviewed by local investigators. A total of 239 patients with a median age of 62 years were included; 67% received 6–8 cycles of CHOP(−like) therapy and 22% received 3–4 cycles, of which 59% also received radiotherapy. Autologous stem cell transplant consolidation was administered to 16% of all patients. Median follow-up was 127 months with 5-years overall survival (OS) of 58% (95% CI: 53–65) and progression-free survival (PFS) of 53% (95% CI: 47–59). In multivariable analysis, age ≥ 60 years and B-symptoms were unfavorable and ALK+ anaplastic large cell T-Cell lymphoma was favorable for survival outcomes. There was no difference in treatment-specific outcome (3–4 cycles vs. 6–8 cycles of CHOP(−like) ± radiotherapy). Low-risk patients (age < 60 without B-symptoms) had a 5-year OS of 77% (95% CI 67–89%). In the present study of limited-stage nodal PTCL, survival after curative intent chemotherapy +/− radiotherapy was inferior to that of limited-stage diffuse large B-cell lymphoma, but a subgroup of young patients without B-symptoms had very good outcomes. Treatment outcomes after 3–4 cycles versus 6–8 cycles of CHOP(−like) therapy were comparable.

When discovered, SN 2017egm was the closest (redshift z = 0.03) hydrogen-poor superluminous supernova (SLSN-I) and a rare case that exploded in a massive and metal-rich galaxy. Thus, it has since been extensively observed and studied. We report spectroscopic data showing strong emission at around He i lambda 10830 and four He i absorption lines in the optical. Consequently, we classify SN 2017egm as a member of an emerging population of helium-rich SLSNe-I (i.e., SLSNe-Ib). We also present our late-time photometric observations. By combining them with archival data, we analyze high-cadence ultraviolet, optical, and near-infrared light curves spanning from early pre-peak (similar to-20 days) to late phases (similar to+300 days). We obtain its most complete bolometric light curve, in which multiple bumps are identified. None of the previously proposed models can satisfactorily explain all main light-curve features, while multiple interactions between the ejecta and circumstellar material (CSM) may explain the undulating features. The prominent infrared excess with a blackbody luminosity of 10(7)-10(8) L (circle dot) detected in SN 2017egm could originate from the emission of either an echo of a pre-existing dust shell or newly formed dust, offering an additional piece of evidence supporting the ejecta-CSM interaction model. Moreover, our analysis of deep Chandra observations yields the tightest-ever constraint on the X-ray emission of an SLSN-I, amounting to an X-ray-to-optical luminosity ratio less than or similar to 10(-3) at late phases (similar to 100-200 days), which could help explore its close environment and central engine.

Peripheral T-Cell Lymphomas (PTCLs) are rare, aggressive lymphomas with poor outcomes, but limited-stage disease is infrequent and not well-described. This study reports outcomes and prognostic factors in limited-stage nodal PTCLs in a binational population-based setting. Patients were identified from the Danish and Swedish lymphoma registries. Adults diagnosed with limited-stage nodal PTCL (stage I-II) and treated with CHOP(−like) therapy ±radiotherapy between 2000 and 2014 were included. Medical records were reviewed by local investigators. A total of 239 patients with a median age of 62 years were included; 67% received 6–8 cycles of CHOP(−like) therapy and 22% received 3–4 cycles, of which 59% also received radiotherapy. Autologous stem cell transplant consolidation was administered to 16% of all patients. Median follow-up was 127 months with 5-years overall survival (OS) of 58% (95% CI: 53–65) and progression-free survival (PFS) of 53% (95% CI: 47–59). In multivariable analysis, age ≥ 60 years and B-symptoms were unfavorable and ALK+ anaplastic large cell T-Cell lymphoma was favorable for survival outcomes. There was no difference in treatment-specific outcome (3–4 cycles vs. 6–8 cycles of CHOP(−like) ± radiotherapy). Low-risk patients (age < 60 without B-symptoms) had a 5-year OS of 77% (95% CI 67–89%). In the present study of limited-stage nodal PTCL, survival after curative intent chemotherapy +/− radiotherapy was inferior to that of limited-stage diffuse large B-cell lymphoma, but a subgroup of young patients without B-symptoms had very good outcomes. Treatment outcomes after 3–4 cycles versus 6–8 cycles of CHOP(−like) therapy were comparable.

We present photometric and spectroscopic observations of SN 2020bio, a double-peaked Type IIb supernova (SN) discovered within a day of explosion, primarily obtained by Las Cumbres Observatory and Swift. SN 2020bio displays a rapid and long-lasting initial decline throughout the first week of its light curve, similarly to other well-studied Type IIb SNe. This early-time emission is thought to originate from the cooling of the extended outer hydrogen-rich (H-rich) envelope of the progenitor star that is shock heated by the SN explosion. We compare SN 2020bio to a sample of other double-peaked Type IIb SNe in order to investigate its progenitor properties. Analytical model fits to the early-time emission give progenitor radius (≈100–1500 R⊙) and H-rich envelope mass (≈0.01–0.5 M⊙) estimates that are consistent with other Type IIb SNe. However, SN 2020bio displays several peculiarities, including (1) weak H spectral features indicating a greater amount of mass loss than other Type IIb progenitors; (2) an underluminous secondary light-curve peak that implies a small amount of synthesized 56Ni (MNi ≈0.02 M⊙); and (3) low-luminosity nebular [O i] and interaction-powered nebular features. These observations are more consistent with a lower-mass progenitor (MZAMS ≈ 12 M⊙) that was stripped of most of its H-rich envelope before exploding. This study adds to the growing diversity in the observed properties of Type IIb SNe and their progenitors.

This dataset consists of the GLODAPv2.2023 data product composed of data from 1108 scientific cruises covering the global ocean between 1972 and 2021. It includes full depth discrete bottle measurements of salinity, oxygen, nitrate, silicate, phosphate, dissolved inorganic carbon (TCO2), total alkalinity (TAlk), CO2 fugacity (fCO2), pH, chlorofluorocarbons (CFC-11, CFC-12, CFC-113, and CCl4), SF6, and various isotopes and organic compounds. It was created by appending data from 23 cruises to GLODAPv2.2022 (Lauvset et al., 2022, NCEI Accession 0257247). The data for salinity, oxygen, nitrate, silicate, phosphate, TCO2, TAlk, pH, CFC-11, CFC-12, CFC-113, CCl4, and SF6 were subjected to primary and secondary quality control. Severe biases in these data have been corrected for, and outliers removed. However, differences in data related to any known or likely time trends or variations have not been corrected for. These data are believed to be accurate to 0.005 in salinity, 1% in oxygen, 2% in nitrate, 2% in silicate, 2% in phosphate, 4 µmol kg-1 in TCO2, 4 µmol kg-1 in TAlk, and for the halogenated transient tracers and SF6: 5%

In this work, we present an optical survey of mm-sized meteoroids using the Canadian Automated Meteor Observatory's (CAMO) mirror tracking system. The system tracks meteors to magnitude +7.5 through an image-intensified telescopic system which has a spatial accuracy of $\sim$1 m and a temporal resolution of 10 ms. We analyze 41 meteors from 13 showers with known parent bodies, recorded between 2016 and 2022. We fit a numerical ablation and fragmentation model to our data which models meteoroid fragmentation as erosion into 10 - 500 $\mu$m constituent grains and uses the observed wake as a hard constraint on the model parameters. We measure average bulk meteoroid densities which are consistent with in situ measurements: 602 $\pm$ 155 kg m$^{-3}$ for Jupiter-family and 345 $\pm$ 48 kg m$^{-3}$ for Halley-type showers. The Geminids had the highest measured bulk density of 1387 $\pm$ 240 kg m$^{-3}$, consistent with carbonaceous material. We fail to reproduce the high bulk density ($>3000$ kg m$^{-3}$) for Jupiter-family meteoroids previously reported in the literature derived using fragmentation models on data sets with fewer observational constraints. We also provide estimates of the meteoroid grain sizes, grain mass distributions, and energy necessary to trigger the erosion for meteoroids in the analyzed showers., Comment: Accepted for publication in Icarus